Analysis
Bottazzi’s core claims about her background and professional achievements are accurate: she emigrated from Honduras in the 1980s, earned a Ph.D. in microbiology, and co-developed **Corbevax**, a patent-free COVID-19 vaccine authorized in India, Indonesia, and other nations. However, the **$300 detail** lacks corroboration in interviews or biographical sources, and while Corbevax was designed for global accessibility, **public data on millions of doses administered is scarce** (as of 2023, production/distribution faced delays). The speech’s emphasis on 'used by millions' may conflate *potential* impact with realized outcomes.
Background
Bottazzi, a professor at Baylor College of Medicine, co-created Corbevax with Peter Hotez; the vaccine uses traditional protein-subunit technology and was intended as a low-cost alternative for low-income countries. Her personal story—immigrating as a young woman and rising in STEM—aligns with public records, though the $300 anecdote appears to be a rhetorical device. Corbevax received emergency use authorization in several countries but competed with mRNA vaccines for adoption.
Verdict summary
Maria Elena Bottazzi did immigrate to the U.S. from Honduras as a teen and co-led development of a COVID-19 vaccine, but the $300 figure is unverified, and her vaccine (Corbevax) has been *authorized* for use in multiple countries though actual distribution numbers remain unclear.